A bacterium's built-in compass, explained: Single-cell magnetometry confirms Earth-field alignment

Some bacterial species possess an astonishing ability: They use Earth's magnetic field to orient themselves. To better understand this mechanism, the team led by Argovia-Professor Martino Poggio from ...

Compass Pathways' depression treatment meets main goal in late‑stage study

Feb 17 (Reuters) - Drug developer Compass Pathways said on Tuesday its psilocybin-based depression therapy reduced the severity of symptoms in a late-stage study, sending its shares up nearly 30%. The ...
Fierce Biotech

Compass guides psychedelic therapy to 2nd pivotal depression win, triggering approval push

Compass Pathways has reported another phase 3 win for its psilocybin therapy in treatment-resistant depression, sending the ...

Compass Pathways: Stock Soars As Data Sets Up Psilocybin Approval Shot

Compass Pathways is rated a Hold due to high risk, funding needs, and the need for further data before reassessing the thesis ...

Compass gains as psychedelic therapy succeeds in late-stage trial for depression

Compass Pathways (CMPS) stock jumps as the company says psychedelic drug COMP360 hit late-stage trial endpoint in ...
BioPharma Dive

Compass, with Phase 3 hits, ready to take psilocybin to the FDA

The company plans to meet with the FDA to discuss a rolling approval application for “COMP360,” a synthetic form of psilocybin that could become the first “classic” psychedelic cleared for the U.S.